Fecal transplant for hidradenitis suppurativa
Treatments studied
Part of Infections, Skin clinical trials.
This trial tests whether a fecal transplant (transfer of healthy gut bacteria) can help control symptoms of moderate to severe hidradenitis suppurativa (HS) that hasn't responded well to standard antibiotics. It aims to see if changing the balance of gut bacteria can reduce skin inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- Your HS is moderate (Hurley II) or very severe (Hurley III).
- You have at least 4 inflammatory lesions (like tender lumps, boils, or draining tunnels) in the armpits/chest or buttock/genital area.
- You've already tried a standard antibiotic treatment and your symptoms returned within 3 months.
- You have not taken biologic treatments (like adalimumab or secukinumab) in the last 3 months.
- You do not have other inflammatory diseases, a weak immune system, or certain infections (like HIV or active hepatitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.
This trial tests a new medication called CIT-013 for people with moderate to severe hidradenitis suppurativa (HS) who have not had enough relief from oral antibiotics. The goal is to see if this treatment can reduce painful bumps and abscesses.
This study looks at certain immune cells (called MAIT cells) in the skin of people with hidradenitis suppurativa, a painful skin condition. It will compare samples from people before they start a new biologic treatment, and may help doctors understand how these treatments work.
This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.
This study tests whether botulinum toxin (Botox) injections can help treat hidradenitis suppurativa (HS), a skin condition with painful bumps. The goal is to see if blocking certain nerve signals can reduce HS flare-ups.
This study tests a drug called secukinumab (a type of biologic that targets inflammation) for people with moderate to severe hidradenitis suppurativa (HS). It may be an option if you have tried other treatments and they didn't work well.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.